1. Home
  2. MMU vs VALN Comparison

MMU vs VALN Comparison

Compare MMU & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Managed Municipals Fund Inc.

MMU

Western Asset Managed Municipals Fund Inc.

HOLD

Current Price

$10.11

Market Cap

561.5M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.00

Market Cap

537.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMU
VALN
Founded
1992
2012
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.5M
537.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MMU
VALN
Price
$10.11
$6.00
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$15.75
AVG Volume (30 Days)
114.4K
140.2K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
4.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.00
Revenue Next Year
N/A
$92.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.46
$5.43
52 Week High
$10.71
$12.25

Technical Indicators

Market Signals
Indicator
MMU
VALN
Relative Strength Index (RSI) 39.49 24.85
Support Level $9.81 $5.69
Resistance Level $10.49 $6.73
Average True Range (ATR) 0.14 0.37
MACD -0.00 -0.28
Stochastic Oscillator 29.99 0.18

Price Performance

Historical Comparison
MMU
VALN

About MMU Western Asset Managed Municipals Fund Inc.

Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: